Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers
US-9321808-B2 · Apr 26, 2016 · US
Peptides for promoting angiogenesis and use thereof
US9610318B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9610318-B2 |
| Application number | US-201113637602-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 25, 2011 |
| Priority date | Mar 26, 2010 |
| Publication date | Apr 4, 2017 |
| Grant date | Apr 4, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to a peptide promoting angiogenesis and novel use thereof. More particularly, the invention relates to peptides promoting angiogenesis, and the use of the peptide for promoting angiogenesis and preventing or treating angiogenesis-related disease. The peptide of the present invention have an excellent effect on promoting angiogenesis. Accordingly, it is useful for preventing or treating angiogenesis-related disease and for preparing regeneration of skin flap, wound and burn healing, implantation of artificial skin and preparation of blood vessels for transplantation.
First claim
Opening claim text (preview).
The invention claimed is: 1. An isolated peptide consisting of the amino acid sequence set forth in SEQ ID NO: 1, wherein the C-terminal end of the peptide is amidated. 2. A composition comprising the isolated peptide of claim 1 . 3. An isolated peptide consisting of the amino acid sequence set forth in SEQ ID NO:2, wherein the C-terminal end of the peptide is amidated. 4. A composition comprising the isolated peptide of claim 3 . 5. An isolated peptide consisting of the amino acid sequence set forth in SEQ ID NO:3, wherein the C-terminal end of the peptide is amidated. 6. A composition comprising the isolated peptide of claim 5 .
Assignees
Inventors
Classifications
Antihypertensives · CPC title
for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title
Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure · CPC title
Drugs for disorders of the cardiovascular system · CPC title
Anorexiants; Antiobesity agents · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9610318B2 cover?
- The present invention relates to a peptide promoting angiogenesis and novel use thereof. More particularly, the invention relates to peptides promoting angiogenesis, and the use of the peptide for promoting angiogenesis and preventing or treating angiogenesis-related disease. The peptide of the present invention have an excellent effect on promoting angiogenesis. Accordingly, it is useful for p…
- Who is the assignee on this patent?
- Cho Dae Ho, Bang Sa Ik, Park Jeong Min, and 8 more
- What technology area does this patent fall under?
- Primary CPC classification C07K5/101. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).